GeoVax Labs, Inc. (GOVX)

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing vaccines and immunotherapies for high-consequence infectious diseases and solid tumor cancers. The company's lead programs include GEO-MVA, a Modified Vaccinia Ankara vaccine candidate for mpox and smallpox, and Gedeptin®, an oncolytic gene-directed therapy for head and neck cancer.